(2026). Mode of action-specific and cause-specific retention of biologic and targeted synthetic disease-modifying antirheumatic drugs in anti-SS-A antibody-positive rheumatoid arthritis: The ANSWER cohort study. PLOS ONE.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Mode of Action-specific and Cause-specific Retention of Biologic and Targeted Synthetic Disease-modifying Antirheumatic Drugs in Anti-SS-A Antibody-positive Rheumatoid Arthritis: The ANSWER Cohort Study."
PLOS ONE 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Mode of Action-specific and Cause-specific Retention of Biologic and Targeted Synthetic Disease-modifying Antirheumatic Drugs in Anti-SS-A Antibody-positive Rheumatoid Arthritis: The ANSWER Cohort Study."
PLOS ONE, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.